Drug–drug interactions are a serious clinical issue. An important mechanism underlying drug–drug interactions is induction or inhibition of drug transporters that mediate the cellular uptake ...

What should investors know? Our latest report on the US drug distribution landscape investigates key industry themes, market share and concentration, deep dives into generic, branded, and ...

The Engineered Exosome drugs landscape is dominated by Biologics, with a focus on Intravenous administration and Oncology therapies. Major players like Codiak BioSciences Inc and Evox Therapeutics ...